| Literature DB >> 31251040 |
Rebecca C Fry, Kezia A Addo, Timothy A Bell, Christelle Douillet, Elizabeth Martin, Miroslav Stýblo, Fernando Pardo-Manuel de Villena.
Abstract
In humans and mice, in utero exposure to inorganic arsenic (iAs) is associated with adverse health outcomes later in life. The contribution of preconception exposure to the adverse outcomes in offspring has never been studied. Here combined in utero and postnatal exposures produce insulin resistance in two collaborative cross strains. Furthermore, combined preconception and in utero exposure resulted in increased birth weight and developed insulin resistance in one strain. Thus, preconception exposure to arsenic may contribute to the metabolic disorders later in life, but the susceptibility to the effects of this exposure is determined, at least in part, by genetics.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31251040 PMCID: PMC6941420 DOI: 10.1021/acs.chemrestox.9b00107
Source DB: PubMed Journal: Chem Res Toxicol ISSN: 0893-228X Impact factor: 3.739